ENRIGHT PATRICK G purchased 117.25K shares of ZENAS BIOPHARMA, INC. on the open market
Open‑market purchase worth $2.25M. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 10/14/2025ACC: 0001193125-25-238326
+117.25K
Net shares
Net buyer
$2.25M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
117.25K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+105.27K
Price / share
$19.00
Trade value
$2M
% of position
6.1%
10/9/2025
1.73M→1.83M
Common Stock
Direct
Shares
+11.99K
Price / share
$20.85
Trade value
$249.99K
% of position
New position
10/9/2025
0.00→11.99K
Total
Net shares
+117.25K
Net value
$2.25M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/9/2025 | P · Purchase | +105.27K | $19.00 | $2M | 6.1% | 1.73M | 1.83M |
| Common Stock Direct | 10/9/2025 | P · Purchase | +11.99K | $20.85 | $249.99K | New position | 0.00 | 11.99K |
| Total | +117.25K | $2.25M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned774.53K
Total
774.53K indirect774.53K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 774.53K | Indirect |
| Total | 774.53K | 774.53K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported